Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ishga iqtibos qilgan ishlar

7 ta ish

Ish: MicroRNA let-7 and viral infections: focus on mechanisms of action

  1. Angiogenesis and prostate cancer: MicroRNAs comes into view

    Jitendra Gupta, Nahla A. Tayyib, Abduladheem Turki Jalil +7

    Sharh maqolaCircular RNAs in diseasesPathology - Research and Practice20232 iqtibos
    ABI

  2. The key role of microRNA-766 in the cancer development

    Jitendra Gupta, Hussein Riyadh Abdul Kareem Al‐Hetty, Murtadha Sh. Aswood +7

    Sharh maqolaMicroRNA in disease regulationFrontiers in Oncology20232 iqtibos
    ABI

  3. A glimpse into let-7e roles in human disorders; friend or foe?

    Shadia Hamoud Alshahrani, Triani Yuliastanti, F. Al-dolaimy +7

    MaqolaMicroRNA in disease regulationPathology - Research and Practice20230 iqtibos
    ABI

  4. Prostate cancer and microRNAs: New insights into apoptosis

    Jitendra Gupta, Waleed K. Abdulsahib, Abduladheem Turki Jalil +6

    Sharh maqolaMicroRNA in disease regulationPathology - Research and Practice20230 iqtibos
    ABI

  5. Exploring the modulation of TLR4 and its associated ncRNAs in cancer immunopathogenesis, with an emphasis on the therapeutic implications and mechanisms underlying drug resistance

    Mohammad Y. Alshahrani, Enwa Felix Oghenemaro, Jasur Rizaev +7

    Sharh maqolaImmune Response and InflammationHuman Immunology20240 iqtibos
    ABI

  6. Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies

    Omer Qutaiba B. Allela, Ali Fawzi Al-Hussainy, Gaurav Sanghvi +9

    Sharh maqolaCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 iqtibos
    ABI

  7. Non-Coding RNAs as key regulators of interferon signaling in cancer immunotherapy: mechanistic insights and clinical prospects

    Usamah Sayed, Waleed K. Abdulsahib, S. Renuka Jyothi +6

    MaqolaCircular RNAs in diseasesClinical and Experimental Medicine20260 iqtibos
    ABI